Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma

P. G. Corrie, W. Qian, B. Basu, J. W. Valle, S. Falk, C. Lwuji, H. Wasan, M. Scott-brown, J. Wadsley, S. Arif, J. Bridgewater, D. Propper, R. Gillmore, A. Gopinathan, R. Skells, P. Bundi, R. Brais, K. Dalchau, L. Bax, A. ChhabraA. Machin, A. Dayim, K. Mcadam, S. Cummins, L. Wall, R. Ellis, A. Anthoney, J. Evans, Y. T. Ma, C. Isherwood, A. Neesse, D. Tuveson, D. I. Jodrell, Daniel H. Palmer

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)
127 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences